Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00433511 Information provided by National Cancer Institute (NCI)

First Received: February 8, 2007 Last Updated: July 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2013 (Final data collection date for primary outcome measure)